Items where Author is "Mirsadraee, M."
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.
Article
(2024) Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial. Frontiers in Immunology. p. 10. ISSN 1664-3224